Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Diwanji TP, Mohindra P, Vyfhuis M, Snider JW 3rd, Kalavagunta C, Mossahebi S, Yu J, Feigenberg S, Badiyan SN.

Transl Lung Cancer Res. 2017 Apr;6(2):131-147. doi: 10.21037/tlcr.2017.04.04. Review.

2.

Image-guided radiotherapy and motion management in lung cancer.

Korreman SS.

Br J Radiol. 2015 Jul;88(1051):20150100. doi: 10.1259/bjr.20150100. Epub 2015 May 8. Review.

3.

Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.

Kesarwala AH, Ko CJ, Ning H, Xanthopoulos E, Haglund KE, O'Meara WP, Simone CB 2nd, Rengan R.

Clin Lung Cancer. 2015 May;16(3):237-44. doi: 10.1016/j.cllc.2014.12.001. Epub 2014 Dec 9.

4.

Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature.

Wink KC, Roelofs E, Solberg T, Lin L, Simone CB 2nd, Jakobi A, Richter C, Lambin P, Troost EG.

Front Oncol. 2014 Oct 29;4:292. doi: 10.3389/fonc.2014.00292. eCollection 2014. Review.

5.

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial.

Zhu Z, Liu W, Gillin M, Gomez DR, Komaki R, Cox JD, Mohan R, Chang JY.

Radiat Oncol. 2014 May 6;9:108. doi: 10.1186/1748-717X-9-108.

6.

The utility of proton beam therapy with concurrent chemotherapy for the treatment of esophageal cancers.

Lin SH.

Cancers (Basel). 2011 Oct 28;3(4):4090-101. doi: 10.3390/cancers3044090.

7.

A serial 4DCT study to quantify range variations in charged particle radiotherapy of thoracic cancers.

Mori S, Dong L, Starkschall G, Mohan R, Chen GT.

J Radiat Res. 2014 Mar 1;55(2):309-19. doi: 10.1093/jrr/rrt114. Epub 2013 Oct 18.

8.

An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer.

Berman AT, Teo BK, Dolney D, Swisher-McClure S, Shahnazi K, Both S, Rengan R.

Radiat Oncol. 2013 Jun 15;8:144. doi: 10.1186/1748-717X-8-144.

9.

A novel dose-based positioning method for CT image-guided proton therapy.

Cheung JP, Park PC, Court LE, Ronald Zhu X, Kudchadker RJ, Frank SJ, Dong L.

Med Phys. 2013 May;40(5):051714. doi: 10.1118/1.4801910.

10.

Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Braunstein S, Nakamura JL.

Front Oncol. 2013 Apr 3;3:73. doi: 10.3389/fonc.2013.00073. eCollection 2013.

11.

Fast range-corrected proton dose approximation method using prior dose distribution.

Park PC, Cheung J, Zhu XR, Sahoo N, Court L, Dong L.

Phys Med Biol. 2012 Jun 7;57(11):3555-69. doi: 10.1088/0031-9155/57/11/3555. Epub 2012 May 16.

12.

Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.

Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1093-100. doi: 10.1016/j.ijrobp.2012.02.041. Epub 2012 Apr 27.

13.

Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer.

Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e273-80. doi: 10.1016/j.ijrobp.2011.12.048. Epub 2012 Mar 21.

14.

Initial validation and clinical experience with 3D optical-surface-guided whole breast irradiation of breast cancer.

Li S, DeWeese T, Movsas B, Liu D, Frassica D, Kim J, Chen Q, Walker E.

Technol Cancer Res Treat. 2012 Feb;11(1):57-68.

15.

Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Simone CB 2nd, Ly D, Dan TD, Ondos J, Ning H, Belard A, O'Connell J, Miller RW, Simone NL.

Radiother Oncol. 2011 Dec;101(3):376-82. doi: 10.1016/j.radonc.2011.05.028. Epub 2011 Jun 12.

16.

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.

Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD.

Cancer. 2011 Oct 15;117(20):4707-13. doi: 10.1002/cncr.26080. Epub 2011 Mar 22.

17.

Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.

Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1350-7. doi: 10.1016/j.ijrobp.2010.04.049. Epub 2011 Jan 20.

18.

Adaptive radiation for lung cancer.

Gomez DR, Chang JY.

J Oncol. 2011;2011. pii: 898391. doi: 10.1155/2011/898391. Epub 2010 Aug 4.

19.

Improving radiation conformality in the treatment of non-small cell lung cancer.

Chang JY, Cox JD.

Semin Radiat Oncol. 2010 Jul;20(3):171-7. doi: 10.1016/j.semradonc.2010.01.005. Review.

20.

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Register SP, Zhang X, Mohan R, Chang JY.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1015-22. doi: 10.1016/j.ijrobp.2010.03.012. Epub 2010 Jul 7.

Supplemental Content

Support Center